• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同α-突触核蛋白毒株在突触核蛋白病中的作用,与其他神经退行性疾病的相似性

Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases.

作者信息

Melki Ronald

出版信息

J Parkinsons Dis. 2015;5(2):217-27. doi: 10.3233/JPD-150543.

DOI:10.3233/JPD-150543
PMID:25757830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4923763/
Abstract

Misfolded protein aggregates are the hallmark of several neurodegenerative diseases in humans. The main protein constituent of these aggregates and the regions within the brain that are affected differ from one neurodegenerative disorder to another. A plethora of reports suggest that distinct diseases have in common the ability of protein aggregates to spread and amplify within the central nervous system. This review summarizes briefly what is known about the nature of the protein aggregates that are infectious and the reason they are toxic to cells. The chameleon property of polypeptides which aggregation into distinct high-molecular weight assemblies is associated to different diseases, in particular, that of alpha-synuclein which aggregation is the hallmark of distinct synucleinopathies, is discussed. Finally, strategies targeting the formation and propagation of structurally distinct alpha-synuclein assemblies associated to different synucleinopathies are presented and their therapeutic and diagnostic potential is discussed.

摘要

错误折叠的蛋白质聚集体是人类多种神经退行性疾病的标志。这些聚集体的主要蛋白质成分以及大脑中受影响的区域因神经退行性疾病的不同而有所差异。大量报告表明,不同疾病的蛋白质聚集体在中枢神经系统内具有传播和扩增的共同能力。本综述简要总结了关于具有传染性的蛋白质聚集体的性质以及它们对细胞有毒性的原因的已知信息。讨论了多肽的变色龙特性,即多肽聚集形成不同的高分子量聚集体与不同疾病相关,特别是α-突触核蛋白的特性,其聚集是不同突触核蛋白病的标志。最后,介绍了针对与不同突触核蛋白病相关的结构不同的α-突触核蛋白聚集体的形成和传播的策略,并讨论了它们的治疗和诊断潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d49/4923763/9531daaf0204/jpd-5-2-jpd150543-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d49/4923763/b469f9336ba0/jpd-5-2-jpd150543-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d49/4923763/9531daaf0204/jpd-5-2-jpd150543-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d49/4923763/b469f9336ba0/jpd-5-2-jpd150543-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d49/4923763/9531daaf0204/jpd-5-2-jpd150543-g002.jpg

相似文献

1
Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases.不同α-突触核蛋白毒株在突触核蛋白病中的作用,与其他神经退行性疾病的相似性
J Parkinsons Dis. 2015;5(2):217-27. doi: 10.3233/JPD-150543.
2
Seeding and propagation of lesions in neurodegenerative diseases: a new paradigm.神经退行性疾病中病变的播散与传播:一种新范式。
Bull Acad Natl Med. 2015 Jun;199(6):809-819.
3
Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies.不同的 α-突触核蛋白菌株及其对 α-突触核蛋白病异质性的影响。
Neurobiol Dis. 2018 Jan;109(Pt B):209-218. doi: 10.1016/j.nbd.2017.07.018. Epub 2017 Jul 24.
4
Alpha-synuclein and the prion hypothesis in Parkinson's disease.α-突触核蛋白与帕金森病的朊病毒假说。
Rev Neurol (Paris). 2018 Nov;174(9):644-652. doi: 10.1016/j.neurol.2018.08.002. Epub 2018 Sep 7.
5
Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.神经退行性疾病中错误折叠蛋白的降解:治疗靶点与策略
Exp Mol Med. 2015 Mar 13;47(3):e147. doi: 10.1038/emm.2014.117.
6
ɑ-Synuclein strains and the variable pathologies of synucleinopathies.α-突触核蛋白毒株与突触核蛋白病的多样病理学表现
J Neurochem. 2016 Oct;139 Suppl 1:256-274. doi: 10.1111/jnc.13595. Epub 2016 Mar 30.
7
Interaction between α-synuclein and other proteins in neurodegenerative disorders.神经退行性疾病中α-突触核蛋白与其他蛋白质之间的相互作用。
ScientificWorldJournal. 2011;11:1893-907. doi: 10.1100/2011/371893. Epub 2011 Oct 24.
8
Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies.tau蛋白病和α-突触核蛋白病发病机制中的朊病毒样机制
Curr Neurol Neurosci Rep. 2014 Nov;14(11):495. doi: 10.1007/s11910-014-0495-z.
9
The role of lipids in α-synuclein misfolding and neurotoxicity.脂质在α-突触核蛋白错误折叠和神经毒性中的作用。
J Biol Chem. 2019 Jun 7;294(23):9016-9028. doi: 10.1074/jbc.REV119.007500. Epub 2019 May 7.
10
Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases.寡聚体病与阿尔茨海默病和帕金森病的发病机制
Mov Disord. 2016 Jun;31(6):771-81. doi: 10.1002/mds.26624. Epub 2016 Mar 31.

引用本文的文献

1
Current Status of α-Synuclein Biomarkers and the Need for α-Synuclein PET Tracers.α-突触核蛋白生物标志物的现状及对α-突触核蛋白PET示踪剂的需求
Cells. 2025 Aug 18;14(16):1272. doi: 10.3390/cells14161272.
2
Parkinson Disease Signaling Pathways, Molecular Mechanisms, and Potential Therapeutic Strategies: A Comprehensive Review.帕金森病信号通路、分子机制及潜在治疗策略:综述
Int J Mol Sci. 2025 Jul 3;26(13):6416. doi: 10.3390/ijms26136416.
3
Potential common pathogenesis of several neurodegenerative diseases.几种神经退行性疾病潜在的共同发病机制。

本文引用的文献

1
Advances in the therapy of Alzheimer's disease: targeting amyloid beta and tau and perspectives for the future.阿尔茨海默病治疗的进展:靶向淀粉样β蛋白和tau蛋白以及未来展望。
Expert Rev Neurother. 2015 Jan;15(1):83-105. doi: 10.1586/14737175.2015.995637. Epub 2014 Dec 24.
2
A novel bio-orthogonal cross-linker for improved protein/protein interaction analysis.一种新型生物正交交联剂,用于改善蛋白质/蛋白质相互作用分析。
Anal Chem. 2015 Feb 3;87(3):1853-60. doi: 10.1021/ac503892c. Epub 2015 Jan 12.
3
Modulation of the maladaptive stress response to manage diseases of protein folding.
Neural Regen Res. 2026 Mar 1;21(3):972-988. doi: 10.4103/NRR.NRR-D-24-01054. Epub 2025 May 30.
4
Intracellular Inclusions Induced by Patient-Derived and Amplified α-Synuclein Aggregates Are Morphologically Indistinguishable.由患者来源并扩增的α-突触核蛋白聚集体诱导产生的细胞内包涵体在形态上无法区分。
Cells. 2025 May 9;14(10):684. doi: 10.3390/cells14100684.
5
Targeting Ferroptosis in Parkinson's Disease: Mechanisms and Emerging Therapeutic Strategies.帕金森病中铁死亡的靶向治疗:机制与新兴治疗策略
Int J Mol Sci. 2024 Dec 4;25(23):13042. doi: 10.3390/ijms252313042.
6
An Update on Recent Drug Delivery Systems Targeting Brain Diseases via the Transnasal Pathway.经鼻腔途径靶向脑部疾病的新型药物传递系统研究进展
Pharm Res. 2024 Nov;41(11):2121-2141. doi: 10.1007/s11095-024-03790-3. Epub 2024 Oct 30.
7
Infections in the Etiology of Parkinson's Disease and Synucleinopathies: A Renewed Perspective, Mechanistic Insights, and Therapeutic Implications.感染在帕金森病和突触核蛋白病病因学中的作用:新视角、机制见解和治疗意义。
J Parkinsons Dis. 2024;14(7):1301-1329. doi: 10.3233/JPD-240195.
8
Unveiling Lobophytum sp. the neuroprotective potential of Parkinson's disease through multifaceted mechanisms, supported by metabolomic analysis and network pharmacology.揭示 Lobophytum sp. 通过多方面机制对帕金森病的神经保护潜力,代谢组学分析和网络药理学提供支持。
Sci Rep. 2024 Sep 18;14(1):21810. doi: 10.1038/s41598-024-66781-9.
9
Exploring Intrinsic Disorder in Human Synucleins and Associated Proteins.探索人类突触核蛋白和相关蛋白中的内源性无序。
Int J Mol Sci. 2024 Aug 1;25(15):8399. doi: 10.3390/ijms25158399.
10
Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissue.来源于人类路易体痴呆组织的α-突触核蛋白纤维的结构。
Nat Commun. 2024 Mar 29;15(1):2750. doi: 10.1038/s41467-024-46832-5.
调节适应不良的应激反应以治疗蛋白质折叠疾病。
PLoS Biol. 2014 Nov 18;12(11):e1001998. doi: 10.1371/journal.pbio.1001998. eCollection 2014 Nov.
4
Transneuronal propagation of mutant huntingtin contributes to non-cell autonomous pathology in neurons.突变亨廷顿蛋白的跨神经元传播导致神经元中非细胞自主的病理学改变。
Nat Neurosci. 2014 Aug;17(8):1064-72. doi: 10.1038/nn.3761. Epub 2014 Jul 13.
5
Latest treatment options for Alzheimer's disease, Parkinson's disease dementia and dementia with Lewy bodies.阿尔茨海默病、帕金森病痴呆和路易体痴呆的最新治疗选择。
Expert Opin Pharmacother. 2014 Sep;15(13):1797-810. doi: 10.1517/14656566.2014.936848. Epub 2014 Jul 3.
6
Distinct synthetic Aβ prion strains producing different amyloid deposits in bigenic mice.不同的合成 Aβ 朊病毒株在双转基因小鼠中产生不同的淀粉样沉积物。
Proc Natl Acad Sci U S A. 2014 Jul 15;111(28):10329-34. doi: 10.1073/pnas.1408968111. Epub 2014 Jun 30.
7
Misfolded proteins in Huntington disease fetal grafts: further evidence of cell-to-cell transfer?亨廷顿病胎儿移植物中的错误折叠蛋白:细胞间转移的进一步证据?
Ann Neurol. 2014 Jul;76(1):20-1. doi: 10.1002/ana.24205. Epub 2014 Jul 9.
8
Α-synuclein immunotherapy blocks uptake and templated propagation of misfolded α-synuclein and neurodegeneration.α-突触核蛋白免疫疗法可阻断错误折叠的α-突触核蛋白的摄取和模板化传播以及神经退行性变。
Cell Rep. 2014 Jun 26;7(6):2054-65. doi: 10.1016/j.celrep.2014.05.033. Epub 2014 Jun 12.
9
Distinct tau prion strains propagate in cells and mice and define different tauopathies.不同的 tau 朊病毒株在细胞和小鼠中传播,并定义了不同的 tau 病。
Neuron. 2014 Jun 18;82(6):1271-88. doi: 10.1016/j.neuron.2014.04.047. Epub 2014 May 22.
10
The organisation of the cell membrane: do proteins rule lipids?细胞膜的组织:蛋白质主宰脂质吗?
Curr Opin Chem Biol. 2014 Jun;20:54-9. doi: 10.1016/j.cbpa.2014.04.009. Epub 2014 May 13.